Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now

Teva Pharma Industries Ltd ADR News

Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now
Allergan PLCJohnson & JohnsonCVS Health Corp
  • 📰 Investingcom
  • ⏱ Reading Time:
  • 42 sec. here
  • 5 min. at publisher
  • 📊 Quality Score:
  • News: 30%
  • Publisher: 53%

Stocks Analysis by MarketBeat.com (Jea Yu) covering: Teva Pharma Industries Ltd ADR, Allergan PLC, Johnson & Johnson, CVS Health Corp. Read MarketBeat.com (Jea Yu)'s latest article on Investing.com

) is the world's largest generic drug maker, with over 500 generic and biosimilar treatments in its broad portfolio. The medical sector giant also has a line of branded drugs driving growth.

TEVA formed a symmetrical triangle with the upper descending trendline forming at the $22.80 swing high and the ascending lower trendline support forming at the $19.03 gap fill. TEVA chopped towards the apex point before gapping down on its earnings release to the $19.75 level and proceeding lower towards the $17.26 fib. Fibonacci pullback support levels are at $17.26, $16.83, $16.25 and $15.81.

Bullish investors can consider using cash-secured puts at the Fib pullback support levels to buy the dip. If assigned the shares, then writing covered calls at upside Fib levels executes a wheel strategy for income.Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Investingcom /  🏆 450. in US

Allergan PLC Johnson & Johnson CVS Health Corp

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

3 Stocks Set to Benefit From Trump’s 'Drill, Baby, Drill' Policy3 Stocks Set to Benefit From Trump’s 'Drill, Baby, Drill' PolicyStocks Analysis by MarketBeat.com (Jea Yu) covering: Boeing Co, Natural Gas Futures, Delta Air Lines Inc, United Airlines Holdings Inc. Read MarketBeat.com (Jea Yu)'s latest article on Investing.com
Read more »

Moderna: Is Stock a Buy? Breaking Down the Latest GuidanceModerna: Is Stock a Buy? Breaking Down the Latest GuidanceStocks Analysis by MarketBeat.com (Jea Yu) covering: Pfizer Inc, GSK plc DRC, Moderna Inc. Read MarketBeat.com (Jea Yu)'s latest article on Investing.com
Read more »

3 Stocks to Gain From Trump’s Return-to-Office Mandate3 Stocks to Gain From Trump’s Return-to-Office MandateStocks Analysis by MarketBeat.com (Jea Yu) covering: Steelcase Inc, Aramark Holdings, Uber Technologies Inc. Read MarketBeat.com (Jea Yu)'s latest article on Investing.com
Read more »

Apple Swings to Outperformer: Is It a Buy Ahead of Earnings?Apple Swings to Outperformer: Is It a Buy Ahead of Earnings?Stocks Analysis by MarketBeat.com (Ryan Hasson) covering: Alphabet Inc Class A, Apple Inc, NVIDIA Corporation, Alphabet Inc Class C. Read MarketBeat.com (Ryan Hasson)'s latest article on Investing.com
Read more »

Why Meta Platforms Stock Is Poised for Another 20%+ Gain in 2025Why Meta Platforms Stock Is Poised for Another 20%+ Gain in 2025Stocks Analysis by MarketBeat.com (Thomas Hughes) covering: Meta Platforms Inc. Read MarketBeat.com (Thomas Hughes)'s latest article on Investing.com
Read more »

Is the Nuclear Energy Sell-Off a Buying Opportunity?Is the Nuclear Energy Sell-Off a Buying Opportunity?Stocks Analysis by MarketBeat.com (Jeffrey Neal Johnson) covering: Cameco Corp, Constellation Energy Corp, Nuscale Power Corp. Read MarketBeat.com (Jeffrey Neal Johnson)'s latest article on Investing.com
Read more »



Render Time: 2025-02-14 22:11:35